(Q37906784)

25 August 2017

1 reference

title

Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods? (English)

1 reference

25 August 2017

0 references

1 reference

2

Benjamin T Ristau

1 reference

25 August 2017

Kara L Watts

1

1 reference

25 August 2017

Harold T Yamase

series ordinal

3

1 reference

25 August 2017

John A Taylor

series ordinal

4

1 reference

25 August 2017

publication date

1 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

108

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

484-492

1 reference

25 August 2017

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Lymph node assessment and lymphadenectomy in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

The role of lymphadenectomy in high-grade invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Lymphadenectomy in bladder cancer: how high is "high enough"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

The concept of lymph node density--is it ready for clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

The Will Rogers phenomenon in urological oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Current status of establishing standards for lymphadenectomy in the treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

The clinical significance of micrometastases and molecular metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

A novel method for real time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Uroplakin gene expression by normal and neoplastic human urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Uroplakin gene expression in normal human tissues and locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10330.X

10.1111/J.1464-410X.2011.10330.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference